Skip to search boxSkip to navigationSkip to main content

Balloon guide catheter impact on angiographic and clinical outcomes in distal medium vessel occlusion stroke thrombectomy

  • Mahmoud H. Mohammaden
    ,
  • Mohamed F. Doheim
    ,
  • Jaydevsinh Dolia
    ,
  • Hend Abdelhamid
    ,
  • Stavros Matsoukas
    ,
  • Braxton Riley Schuldt
*Corresponding author for this work
  • Emory School of Medicine
    ,
  • Grady Memorial Hospital Atlanta
    ,
  • Faculty of Medicine
    ,
  • University of Pittsburgh School of Medicine
    ,
  • Icahn School of Medicine at Mount Sinai
    ,
  • University of Pittsburgh Medical Center
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 639-646 (8 pages)

Journal (Volume, Issue Number)

Journal of NeuroInterventional Surgery (Volume 18, Issue 3)

Publication milestones

  • Published - 01/03/2026

Publication status

Published - 01/03/2026

ISSN

1759-8478

Publication IDs

  • Scopus: 105004402778
  • PubMed: 40274405

Abstract

Background The use of balloon guide catheter (BGC) has been associated with better reperfusion and clinical outcomes in mechanical thrombectomy (MT) for large vessel occlusion stroke. However, the impact of BGC on angiographic and clinical outcomes in patients with distal medium vessel occlusion (DMVO) strokes undergoing MT has not been extensively investigated. Methods This is a retrospective analysis of a prospectively collected database from 14 comprehensive stroke centers in the United States and Europe. Patients with anterior circulation DMVO due to middle cerebral artery (MCA) M3/M4 or anterior cerebral artery (ACA) A1/A2-3 were included. The cohort was divided into BGC and non-BGC groups. Multivariable logistic regression and inverse probability of treatment weighting (IPTW) were used for comparison. The primary outcome was first pass effect (FPE) defined as modified treatment in cerebral infarction (mTICI) grade 2C/3 after single device pass. Results Among 199 patients who were eligible for analysis, 81 (40.7%) were female. The median age was 69 (60-81) years, and National Institutes of Health Stroke Scale score was 13 (7–18). The BGC group (n=73) had higher rates of FPE (53.4% vs 13.7%; IPTW aOR 5.63, 95%CI (2.43 to 13.10), P<0.001) compared with the non-BGC group (n=126). The BGC group had higher rates of modified Rankin Scale (mRS) 0-1 (42.9% vs 27.1%; IPTW aOR 2.78, 95% CI (1.10 to 7.07), P=0.031), mRS 0-2 (60.3% vs 41.5%; IPTW aOR 4.31, 95% CI (1.66 to 11.19), P=0.003), and lower rates of mortality at 90-days (12.7% vs 25.4%; IPTW aOR 0.32, 95% CI (0.11 to 0.98), P=0.047) compared with the non-BGC group. The rates of successful reperfusion at the end of the procedure and symptomatic intracerebral hemorrhage were comparable between both groups. Conclusion The present study suggests that the use of BGC in DMVO undergoing MT may be associated with improved angiographic and clinical outcomes with no safety concerns. Prospective studies are warranted.

Publication metrics

Metrics

Scopus
citations

PlumX, opens in new tab

Citation count
3
Captures
3